0.40 USD
▼-0.02-4.35%
盘后 0.47 0.00%
2026-09-16
市值
$2.99M
市盈率
—
EPS
-8.75
股息率
—
52 周区间
0.40 – 17.74
成交量
196.03K
Beta
3.65
目标价
10.00
52W 低 0.4052W 高 17.74
价格走势
公司简介
GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms in the United States. It develops GEO-CM04S1, a vaccine candidate that is in Phase 2 clinical trial for the treatment of preventive COVID-19; Gedeptin, a novel patented product/technology for the treatment of solid tumors, and Phase 1/2 clinical trial for the treatment of advanced head and neck squamous cell carcinoma; and GEO-CM02, a pan-coronavirus vaccine....